Showing results (311-320 of 356) with videos related to

Sort By:
Pageof 36
Chembiochem : a European Journal of Chemical Biology|September 4, 2024
Previously Published Phosphatase Probes have Limited Utility Due to their Unspecific ReactivityF H G Ter Brake, S A F M van Luttikhuizen, T van der Wel, et al.
The Journal of Biological Chemistry|February 25, 2023
Citrullinated human and murine MOG35-55 display distinct biophysical and biochemical behaviorW Doelman, R C Reijnen, N Dijksman, et al.
Protein Science : a Publication of the Protein Society|October 1, 1995
Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activityM B Kroeger Smith, C A Rouzer, L A Taneyhill, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|November 13, 2017
The OARSI core set of performance-based measures for knee osteoarthritis is reliable but not valid and responsiveJ J Tolk, R P A Janssen, C A C Prinsen, et al.
Pharmacogenetics and Genomics|February 24, 2006
P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influxRainer Büscher, André Hoerning, Hemal H Patel, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU)D W Ludovici, M J Kukla, P G Grous, et al.
Experientia|December 15, 1977
Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediatorsF Awouters, C J Niemegeers, J Van den Berk, et al.
Physics in Medicine and Biology|November 13, 2024
Comparison of contrast-enhanced ultrasound imaging (CEUS) and super-resolution ultrasound (SRU) for the quantification of ischaemia flow redistribution: a theoretical studyLachlan J M B Arthur, Vasiliki Voulgaridou, Mairead B Butler, et al.
Journal of Chemical Information and Modeling|October 30, 2018
Drug Discovery Maps, a Machine Learning Model That Visualizes and Predicts Kinome-Inhibitor Interaction LandscapesAntonius P A Janssen, Sebastian H Grimm, Ruud H M Wijdeven, et al.
Talanta|October 31, 2008
Improving QSAR models for the biological activity of HIV Reverse Transcriptase inhibitors: Aspects of outlier detection and uninformative variable eliminationM Daszykowski, I Stanimirova, B Walczak, et al.
Pageof 36